FIOCRUZ HIV/AIDS Clinical Trials Unit: advancing HIV prevention and treatment in Brazil
Official title: The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
Funded at Fundacao Oswaldo Cruz · NIH-11601065 · Data updated 2026-11-12
A Brazilian clinical trials unit led by Dr. Beatriz Grinsztejn is testing and speeding up new HIV prevention and treatment strategies to help people living with HIV/AIDS and those at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fundacao Oswaldo Cruz NIH-funded |
| Lab location | 1 site (Rio de Janeiro, BRAZIL) |
| Project start | September 1, 2026 |
| Project end | November 30, 2026 |
| Funding year | 2026 |
| Award (this year) | $633,331 |
| NIH project number | 3UM1AI069476-19S1 |
| Project ID | NIH-11601065 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include adults living with HIV/AIDS or at risk of HIV infection who meet trial-specific eligibility criteria and are willing to participate in registered clinical trials in Brazil.
✕Less likely to help
People who do not meet eligibility criteria or who are not interested in trial participation may not benefit.
What this research studies
The FioTrials CTU at FIOCRUZ in Rio de Janeiro brings together experienced researchers and junior investigators to run well-regulated HIV/AIDS clinical trials. It emphasizes standardized, high-quality implementation and management of trials that have shaped HIV and TB prevention and treatment in the past. The unit collaborates with established networks to ensure regulatory compliance, ethical oversight, and robust data collection. Participants may benefit from access to innovative therapies and close medical monitoring through trial participation.
Why it matters
Potential benefit: If successful, the work could lead to faster access to effective HIV prevention and treatment options and stronger care standards for people affected by HIV/AIDS.
How similar studies have gone: Previous NIH-sponsored networks involving FioTrials have changed HIV/AIDS prevention and treatment approaches and achieved regulatory milestones.
Where this research is happening
-
Fundacao Oswaldo Cruz
Rio de Janeiro, Brazil Active
Researchers
- Principal investigator: Grinsztejn, Beatriz — Fundacao Oswaldo Cruz
- Study coordinator: Grinsztejn, Beatriz
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
Breeding colony expansion to support HIV/AIDS research with rhesus macaques
A funding opportunity to expand a specialized Rhesus macaque breeding population to support HIV/AIDS research at Tulane’s primate facility.
-
HIV Resilience Observatory in a rhesus macaque colony expansion
A program to build a rhesus macaque breeding colony and use AI-powered monitoring to study why some HIV/AIDS outcomes differ among individuals with similar backgrounds.
-
Indoor-Outdoor Housing Expansion to Support HIV/AIDS-Related Research
A HIV-focused project at a primate research center will use new indoor/outdoor housing and AI-assisted monitoring to study why people with similar backgrounds can have very different HIV outcomes.
-
Hearing changes in people with HIV and in people without HIV in Tanzania
This project follows people living with HIV and similar individuals in Tanzania to see how hearing and brain function relate over time and whether hearing tests can help predict cognitive changes.
-
Bridging clinic and community care for HIV-positive women facing abuse
A program will adapt and use an evidence-based approach called CUES to help women living with HIV who experience intimate partner violence get better HIV and mental health outcomes by coordinating care with community organizations.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.